AstraZeneca PLC (OTCMKTS:AZNCF) Declares Dividend Increase – $2.10 Per Share

AstraZeneca PLC (OTCMKTS:AZNCF) declared a dividend on Thursday, February 6th,NASDAQ Dividends reports. Investors of record on Friday, February 21st will be given a dividend of 2.10 per share on Monday, March 24th. The ex-dividend date of this dividend is Wednesday, February 19th. This is a boost from AstraZeneca’s previous dividend of $1.00.

AstraZeneca Trading Up 12.5 %

Shares of AstraZeneca stock traded up $16.83 during trading on Thursday, reaching $151.50. 922 shares of the stock traded hands, compared to its average volume of 2,700. AstraZeneca has a 52-week low of $118.16 and a 52-week high of $175.00. The business has a fifty day simple moving average of $134.05 and a two-hundred day simple moving average of $146.53.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.